Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shandong Ruisheng Pharmaceutical Excipient is a specialized manufacturer of pharmaceutical excipients based in Qufu, China. The company focuses on the research, development, and production of essential additives for solid oral dosage forms, including binders, disintegrants, and lubricants. Their core product portfolio features microcrystalline cellulose, croscarmellose sodium, and sodium starch glycolate, all produced in compliance with international GMP standards. Shandong Ruisheng serves a global clientele, providing technical support and high-quality materials to pharmaceutical and nutraceutical manufacturers. The company maintains several Drug Master File (DMF) registrations, facilitating the regulatory approval process for its customers' finished products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shandong Ruisheng Pharmaceutical Excipient.